ROYCE & ASSOCIATES LP – Haemonetics Corporation Transaction History
ROYCE & ASSOCIATES LP portfolio value:
$64.76M
portfolio value
ROYCE & ASSOCIATES LP quarter portfolio value change:
+13.58%
quarter
Haemonetics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.95% | 33.22K shares | 9.90M | $74.03 | 874.80K |
| Q2 2022 | share | Increase | +11.14% | 84.34K shares | 6.98M | $65.18 | 841.58K |
| Q1 2022 | share | Increase | +6.94% | 49.13K shares | 10.31M | $63.22 | 757.24K |
| Q4 2021 | share | Decrease | -28.06% | -276.25K shares | -31.92M | $53.56 | 708.10K |
| Q3 2021 | share | Increase | +63.64% | 382.81K shares | 29.39M | $70.59 | 984.35K |
| Q2 2021 | share | Increase | +28.38% | 132.96K shares | -11.93M | $66.64 | 601.54K |
| Q1 2021 | share | Decrease | -21.74% | -130.17K shares | -19.08M | $111.01 | 468.58K |
| Q4 2020 | share | Increase | +2.60% | 15.14K shares | 20.18M | $118.75 | 598.75K |
| Q3 2020 | share | Increase | +18.33% | 90.41K shares | 6.75M | $87.25 | 583.60K |
| Q2 2020 | share | Increase | +30.96% | 116.58K shares | 6.63M | $89.56 | 493.19K |
| Q1 2020 | share | Increase | +1148.32% | 346.43K shares | 34.06M | $99.66 | 376.60K |
| Q4 2019 | share | Increase | 0.00% | 30.16K shares | 3.46M | $114.9 | 30.16K |
| Q3 2018 | share | Decrease | -100.00% | -19.3K shares | -1.73M | $114.58 | 0 |
| Q2 2018 | share | Decrease | -3.50% | -700 shares | 268K | $89.68 | 19.3K |
| Q1 2018 | share | Increase | +9515.38% | 19.79K shares | 1.45M | $73.16 | 20K |
| Q4 2017 | share | Decrease | -16.47% | -41 shares | 1K | $58.08 | 208 |
| Q3 2017 | share | Increase | 0.00% | 249 shares | 11K | $44.87 | 249 |